VIRX

Viracta Therapeutics Appoints Faerm As CFO

(RTTNews) - Viracta Therapeutics, Inc. (VIRX) announced on Tuesday the appointment of Michael Faerm as chief financial officer, effective immediately.

Faerm brings in over 25 years of experience in life sciences companies, equity research, and investment banking.

Most recently, he has been serving as Interim Chief Financial Officer at Harpoon Therapeutics, Inc.

In pre-market activity on the Nasdaq, the shares are trading at $0.77, up 1.45%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.